Skip to main content
PTGX logo

PTGX · Protagonist Therapeutics, Inc · Webcasts, Transcripts & Audio

Track PTGX — free
$127.16 +2.49 (+2.00%) At close · Nov 18 Q4 2020 earnings call transcript
Market Cap
$8.30B
Shares
65.27M
Volume · Nov 18 433.18K Avg daily vol (3M) 666.83K

Protagonist Therapeutics, Inc Webcasts

Earnings calls, investor updates, investor days and conferences for Protagonist Therapeutics, Inc (PTGX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-11-17
Protagonist Therapeutics, Inc (PTGX) November 17, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-10
Protagonist Therapeutics, Inc (PTGX) November 10, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Investor Update
Investor event
2026-11-09
Protagonist Therapeutics, Inc (PTGX) November 9, 2026 Investor Update
No reported result — non-financial event
Audio Transcript Slides
Investor Update
Investor event
2026-11-06
Protagonist Therapeutics, Inc (PTGX) November 6, 2026 Investor Update
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-10
Protagonist Therapeutics, Inc (PTGX) September 10, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Capital Markets Day
Investor event
2026-09-08
Protagonist Therapeutics, Inc (PTGX) September 8, 2026 Capital Markets Day
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-05
Protagonist Therapeutics, Inc (PTGX) Q2 2026 Earnings Call
Revenue
$213.47M
▲ 3749.2% YoY
Diluted EPS
$2.29
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-03
Protagonist Therapeutics, Inc (PTGX) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-03-12
Protagonist Therapeutics, Inc (PTGX) March 12, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q2
2025-08-06
Protagonist Therapeutics, Inc (PTGX) Q2 2025 Earnings Call
Revenue
$5.55M
▲ 33.1% YoY
Diluted EPS
$-0.55
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Protagonist Therapeutics, Inc (PTGX) Q1 2025 Earnings Call
Revenue
$28.32M
▼ 88.9% YoY
Diluted EPS
$-0.19
▼ 105.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-21
Protagonist Therapeutics, Inc (PTGX) Q4 2024 Earnings Call
Revenue
$170.64M*
▲ 184.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q4
2021-03-10
Protagonist Therapeutics, Inc (PTGX) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q1
2020-05-07
Protagonist Therapeutics, Inc (PTGX) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-10
Protagonist Therapeutics, Inc (PTGX) Q4 2019 Earnings Call
Revenue
$2.72M
▲ 15.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–15 of 15 webcasts
Key facts CIK 1377121 CUSIP 74366E102 13F (30d) 382 filings 356 filers Visit website Investor relations